Benzinga | Apr 22, 2021 04:13PM EDT

Plus Therapeutics Q1 EPS $(0.33) Beats $(0.34) Estimate

Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 17.86 percent decrease over losses of $(0.28) per share from the same period last year.